M

Medannex Ltd

12 employees

Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cancer
T cell modulation
Antibody development
Skills development
Research
SLE
Clinical Trials
oncology
Collaboration
Inflammation
Innovation
Lupus
Autoimmune diseases

Date founded

2009

Funding rounds raised

Total raised

$14M

from 1 investors over 1 rounds

M

Medannex Ltd raised $14M on September 6, 2019

Investors: Morningside Venture Capital 晨兴资本

FAQ